Cognex (CGNX) Stock Forecast, Price & News

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 1 sell rating, 5 hold ratings, 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cognex stock.
View analyst ratings for Cognex or view top-rated stocks.

13 equities research analysts have issued 1 year price objectives for Cognex's shares. Their CGNX stock forecasts range from $41.00 to $80.00. On average, they anticipate Cognex's stock price to reach $59.50 in the next twelve months. This suggests a possible upside of 24.1% from the stock's current price.
View analysts' price targets for Cognex or view top-rated stocks among Wall Street analysts.

Cognex's stock was trading at $77.76 on January 1st, 2022. Since then, CGNX shares have decreased by 38.3% and is now trading at $47.94.
View the best growth stocks for 2022 here.

Cognex saw a increase in short interest in July. As of July 15th, there was short interest totaling 5,790,000 shares, an increase of 19.9% from the June 30th total of 4,830,000 shares. Based on an average trading volume of 1,220,000 shares, the days-to-cover ratio is currently 4.7 days. Currently, 3.5% of the shares of the stock are short sold.
View Cognex's Short Interest.

Cognex is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our earnings forecast for Cognex.

Cognex Co. (NASDAQ:CGNX) released its quarterly earnings results on Tuesday, August, 2nd. The scientific and technical instruments company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.05. Cognex had a net margin of 23.82% and a trailing twelve-month return on equity of 19.19%. During the same quarter in the previous year, the firm earned $0.43 EPS.

Cognex declared a quarterly dividend on Tuesday, August 2nd. Stockholders of record on Friday, August 19th will be given a dividend of $0.065 per share on Friday, September 2nd. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date of this dividend is Thursday, August 18th.
View Cognex's dividend history.

Cognex(NASDAQ:CGNX) pays an annual dividend of $0.26 per share and currently has a dividend yield of 0.54%. Cognex has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Cognex is 17.81%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cognex will have a dividend payout ratio of 18.44% next year. This indicates that Cognex will be able to sustain or increase its dividend.
View Cognex's dividend history.

Cognex shares split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly issued shares were distributed to shareholders after the closing bell on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex updated its third quarter 2022 earnings guidance on Tuesday, August, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $160.00 million-$180.00 million, compared to the consensus revenue estimate of $290.25 million.

94 employees have rated Cognex CEO Robert Willett on Glassdoor.com. Robert Willett has an approval rating of 84% among Cognex's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cognex investors own include NVIDIA (NVDA), Alibaba Group (BABA), PayPal (PYPL), Netflix (NFLX), Micron Technology (MU), Advanced Micro Devices (AMD), Arista Networks (ANET), Activision Blizzard (ATVI), Block (SQ) and Walt Disney (DIS).

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.18%), Sumitomo Mitsui Trust Holdings Inc. (1.12%), DekaBank Deutsche Girozentrale (0.68%), Front Street Capital Management Inc. (0.55%), Stephens Investment Management Group LLC (0.50%) and Royce & Associates LP (0.40%). Company insiders that own Cognex stock include Anthony Sun, Carl Gerst, Dianne M Parrotte, Eugene G Banucci, Jerry A Schneider, Jerry A Schneider, Laura Ann Macdonald, Patrick Alias, Paul Todgham, Robert Willett, Sheila Marie Dipalma and Theodor Krantz.
View institutional ownership trends for Cognex.

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CGNX stock can currently be purchased for approximately $47.94.

Cognex (NASDAQ:CGNX) has a market capitalization of $8.31 billion and generates $1.04 billion in revenue each year. The scientific and technical instruments company earns $279.88 million in net income (profit) each year or $1.46 on an earnings per share basis.

Cognex employs 2,257 workers across the globe.

Cognex was founded in 1981.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The official website for Cognex is www.cognex.com. The scientific and technical instruments company can be reached via phone at (508) 650-3000, via email at susan.conway@cognex.com, or via fax at 508-650-3333.